The pharmacokinetics (PK) of praziquantel are altered by coadministration of ketoconazole

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

A Novel Gibbs Maximum a Posteriori (GMAP) Approach on Bayesian Nonlinear Mixed-Effects Population Pharmacokinetics (PK) Models

By Kim Seongho  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 700-720

Taylor & Francis Ltd

Access to resources Recommend Favorite

The pharmacokinetics (PK) of aprepitant are not affected in patients with end-stage renal disease (ESRD) or severe renal impairment

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of the Peripheral Benzodiazepine Receptor Antagonist, Pk 11195, in Rats. The Effect of Dose and Gender

By Wala E.P.   Sloan J.W.   Jing X.  

Pharmacological Research, Vol. 41, Iss. 4, 2000-04 ,pp. : 461-468

Academic Press

Access to resources Recommend Favorite

Pharmacokinetics/Pharmacodynamics (PK/PD) Modeling of Risks of Kidney Toxicity from Exposure to Cadmium: Estimates of Dietary Risks in the U.S. Population

By Diamond Gary   Thayer William   Choudhury Harlal  

Journal of Toxicology and Environmental Health, Vol. 66, Iss. 22, 2003-01 ,pp. : 2141-2164

Taylor & Francis Ltd

Access to resources Recommend Favorite